Westfield Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-42,706
| Closed | -$3.29M | – | 232 |
|
|
2022
Q2 | $3.29M | Sell |
42,706
-49,384
| -54% | -$3.76M | 0.03% | 208 |
|
|
2022
Q1 | $6.72M | Sell |
92,090
-3,050
| -3% | -$205K | 0.04% | 193 |
|
|
2021
Q4 | $5.93M | Sell |
95,140
-820
| -0.9% | -$48.1K | 0.04% | 197 |
|
|
2021
Q3 | $5.68M | Buy |
95,960
+440
| +0.5% | +$29K | 0.03% | 200 |
|
|
2021
Q2 | $6.38M | Sell |
95,520
-268,028
| -74% | -$17.5M | 0.04% | 199 |
|
|
2021
Q1 | $23M | Sell |
363,548
-1,481,644
| -80% | -$92.2M | 0.14% | 166 |
|
|
2020
Q4 | $114M | Sell |
1,845,192
-200,784
| -10% | -$12.3M | 0.68% | 46 |
|
|
2020
Q3 | $123M | Buy |
2,045,976
+131,540
| +7% | +$7.92M | 0.8% | 36 |
|
|
2020
Q2 | $113M | Sell |
1,914,436
-2,633
| -0.1% | -$157K | 0.77% | 36 |
|
|
2020
Q1 | $107M | Buy |
1,917,069
+399,439
| +26% | +$24.4M | 0.94% | 31 |
|
|
2019
Q4 | $97.4M | Sell |
1,517,630
-157,223
| -9% | -$9M | 0.69% | 46 |
|
|
2019
Q3 | $84.9M | Sell |
1,674,853
-517,865
| -24% | -$24.3M | 0.68% | 48 |
|
|
2019
Q2 | $99.4M | Sell |
2,192,718
-1,085,523
| -33% | -$50.6M | 0.75% | 42 |
|
|
2019
Q1 | $156M | Buy |
+3,278,241
| New | +$163M | 1.19% | 15 |
|
|
2018
Q4 | – | Sell |
-1,463,591
| Closed | -$90.9M | – | 245 |
|
|
2018
Q3 | $90.9M | Buy |
1,463,591
+225,364
| +18% | +$13.4M | 0.64% | 50 |
|
|
2018
Q2 | $68.5M | Buy |
+1,238,227
| New | +$66.9M | 0.51% | 64 |
|
|
2017
Q2 | – | Sell |
-1,150,962
| Closed | -$62.6M | – | 257 |
|
|
2017
Q1 | $62.6M | Sell |
1,150,962
-1,260,443
| -52% | -$69.1M | 0.54% | 61 |
|
|
2016
Q4 | $141M | Sell |
2,411,405
-146,457
| -6% | -$8.01M | 1.24% | 14 |
|
|
2016
Q3 | $138M | Sell |
2,557,862
-161,685
| -6% | -$10.4M | 1.11% | 17 |
|
|
2016
Q2 | $200M | Sell |
2,719,547
-401,148
| -13% | -$28.3M | 1.65% | 7 |
|
|
2016
Q1 | $199M | Buy |
3,120,695
+199,521
| +7% | +$12.6M | 1.52% | 10 |
|
|
2015
Q4 | $201M | Buy |
2,921,174
+2,790,844
| +2,141% | +$184M | 1.35% | 9 |
|
|
2015
Q3 | $7.72M | Sell |
130,330
-1,320
| -1% | -$83.7K | 0.05% | 194 |
|
|
2015
Q2 | $8.76M | Buy |
131,650
+43,320
| +49% | +$2.85M | 0.05% | 214 |
|
|
2015
Q1 | $5.7M | Buy |
88,330
+22,540
| +34% | +$1.41M | 0.03% | 238 |
|
|
2014
Q4 | $3.88M | Sell |
65,790
-24,380
| -27% | -$1.37M | 0.02% | 245 |
|
|
2014
Q3 | $4.62M | Buy |
90,170
+4,510
| +5% | +$225K | 0.03% | 237 |
|
|
2014
Q2 | $4.16M | Sell |
85,660
-3,488,354
| -98% | -$172M | 0.02% | 241 |
|
|
2014
Q1 | $186M | Sell |
3,574,014
-79,922
| -2% | -$4.25M | 1.11% | 12 |
|
|
2013
Q4 | $194M | Sell |
3,653,936
-776,929
| -18% | -$39.6M | 1.14% | 11 |
|
|
2013
Q3 | $205M | Buy |
4,430,865
+776,443
| +21% | +$34.1M | 1.31% | 5 |
|
|
2013
Q2 | $163M | Buy |
+3,654,422
| New | +$159M | 1.12% | 11 |
|
Other funds holding BMY
Westfield Capital Management's BMY Position: Q3 2022 in Review
Westfield Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 42,706 shares — an estimated $3.29M sold.
Westfield Capital Management first reported a position in BMY in Q2 2013 and held it in 32 quarters. The position peaked at $205M in Q3 2013. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- Westfield Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
- Westfield Capital Management sold 42,706 Bristol-Myers Squibb shares in Q3 2022, an estimated $3.29M.
- Westfield Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 32 quarters.
- Westfield Capital Management's Bristol-Myers Squibb position peaked at $205M in Q3 2013.
- 2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on Westfield Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.